Home > Insider Trading > Filing (0001801385-24-000011)

Filing Details

Accession Number:: 0001801385-24-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-01 20:20:02
Reporting Period:: 2024-02-28

Accepted Time:: 2024-03-01 20:20:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1711279	Krystal Biotech Inc.	KRYS	Biological Products, (No Disgnostic Substances) (2836)	821080209

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801385	Kathryn Romano	C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-28	648	$63.55	13,584	No	4	M	Direct
Common Stock	Disposition	2024-02-28	648	$162.71	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	900	$63.55	13,836	No	4	M	Direct
Common Stock	Disposition	2024-02-28	900	$163.68	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	1,429	$63.55	14,365	No	4	M	Direct
Common Stock	Disposition	2024-02-28	1,429	$164.81	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	300	$63.55	13,236	No	4	M	Direct
Common Stock	Disposition	2024-02-28	300	$166.06	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	300	$63.55	13,236	No	4	M	Direct
Common Stock	Disposition	2024-02-28	300	$167.85	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	1,216	$63.55	14,152	No	4	M	Direct
Common Stock	Disposition	2024-02-28	1,216	$169.09	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	117	$63.55	13,053	No	4	M	Direct
Common Stock	Disposition	2024-02-28	117	$169.82	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	90	$63.55	13,026	No	4	M	Direct
Common Stock	Disposition	2024-02-28	90	$172.23	12,936	No	4	S	Direct
Common Stock	Acquisiton	2024-02-28	5,000	$0.00	17,936	No	4	M	Direct
Common Stock	Disposition	2024-02-28	2,314	$163.08	15,622	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-28	5,000	$0.00	5,000	$63.55
Common Stock	Performance Stock Units	Disposition	2024-02-28	5,000	$0.00	5,000	$0.00
Common Stock	Performance Stock Units	Acquisiton	2024-02-29	15,000	$0.00	15,000	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000	2032-02-28	No	4	M	Direct
5,000		No	4	M	Direct
15,000		No	4	A	Direct

Footnotes

The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 5,000 shares with a limit price of $150.00 per share.
The transaction was executed in multiple trades ranging from $162.155 to $163.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $163.190 to $164.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $164.300 to $165.220. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $165.980 to $166.110. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from$167.540 to $168.010. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $168.680 to $169.610. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $169.790 to $170.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
10,000 performance stock units ("PSUs") were granted on February 28, 2023. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 312023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. All of the performance criteria were achieved and one-half of the PSUs granted, or5,000 PSUs, vested on February 28, 2024.
Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 5,000 PSUs on February 28, 2024.
The closing price on February 28, 2024 of the Company's common stock on NASDAQ.
50,000 options were granted that vest in four equal annual installments with the first installment vesting on February 28, 2023.
Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. All of the performance criteria were achieved and one-half of the PSUs granted, or 5,000 PSUs, vested on February 28, 2024.
The Performance Stock Units vest ratably over a two-year period with the first installment vesting on February 28, 2024.
Each PSU represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement.
The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the performance criteria set by the Company's Compensation Committee for this PSU award and full vesting.
If any applicable portion of the performance criteria have been achieved, the PSU award shall vest in two equal annual installments (February 28, 2025 and February 28, 2026).
If some or all of the performance criteria are not achieved, the applicable portion of the PSU award will be forfeited.